Begin typing your search...
Showing results for "#Phase III trials"
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials,...
Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III...